Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma

Published:2022 Issue: Volume:20 Page:4390-4401
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Wang Ning,Zhu Lingye,Xu Xiaomei,Yu Chang,Huang Xiaoying

Funder

Wenzhou Municipal Science and Technology Bureau

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference31 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Commensal microbiota promote lung cancer development via γδ T cells;Jin;Cell,2019

3. Lung cancer;Brody;Nature,2020

4. Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer;Aggarwal;JAMA Oncol,2019

5. Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers;Drilon;Ann Oncol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Gene Signature based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients;Current Medicinal Chemistry;2024-11

2. ACAP1 could serve as a novel prognostic biomarker associated with tumor immunity in clear-cell renal cell carcinoma: A comprehensive analysis by integrating bulk and single-cell sequencing;Asian Journal of Surgery;2024-09

3. Acyl-CoA Thioesterase 8 (ACOT8) is a Poor Prognostic Biomarker in Breast Cancer;Pharmacogenomics and Personalized Medicine;2024-08

4. The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer;Journal of Gastrointestinal Oncology;2024-02

5. Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing;Therapeutic Advances in Medical Oncology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3